| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/13/2006 | EP1699434A1 Process for preparing a medicament |
| 09/13/2006 | EP1699431A2 Compositions for treatment of ear disorders and methods of use thereof |
| 09/13/2006 | EP1699430A1 Patch |
| 09/13/2006 | EP1699421A2 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 09/13/2006 | EP1699420A1 Membranes incorporating recognition moieties |
| 09/13/2006 | EP1699398A2 Enhancement of immune responses |
| 09/13/2006 | EP1699365A2 Treatment of skin using a benefit agent and an apparatus |
| 09/13/2006 | EP1664033A4 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof |
| 09/13/2006 | EP1628642B1 Controlled drug release composition resistant to in vivo mechanic stress |
| 09/13/2006 | EP1626726B1 Use of lornoxicam or lornoxicam analogue compounds |
| 09/13/2006 | EP1613326B1 (3-{3-'(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino]-propoxy}-phenyl)-acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders |
| 09/13/2006 | EP1562610B1 Combination therapy with gemcitabine and zd6126 |
| 09/13/2006 | EP1532145B1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 09/13/2006 | EP1524976B1 A non-hormonal approach to male contraception |
| 09/13/2006 | EP1513942B1 Galactosyl isomalt, method for production and use thereof |
| 09/13/2006 | EP1511752B1 Camptothecins with a modified lactone ring |
| 09/13/2006 | EP1497274B1 Terphenyl derivatives, preparation thereof, compositions containing same |
| 09/13/2006 | EP1487424B1 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases |
| 09/13/2006 | EP1485394B1 Process for isolation of eupalitin (3-o-beta-d-galactopyranoside) from boerhavia diffusa |
| 09/13/2006 | EP1483257B1 Quinazoline compounds useful in therapy |
| 09/13/2006 | EP1453527B1 Method for obtaining oestrogen from mare urine |
| 09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 09/13/2006 | EP1430060B1 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors. |
| 09/13/2006 | EP1414813B1 1,2,4-trioxolane antimalarials |
| 09/13/2006 | EP1414465B1 Use of inhibitors of progesterone receptor for treating steroid resistant breast cancer |
| 09/13/2006 | EP1412364B1 Platelet adp receptor inhibitors |
| 09/13/2006 | EP1406881B1 11-piperazinyldibenzo(b,f)(1,4)oxazepines and thiazepines as atypical antipsychotic agents having low affinity for the d2 receptor |
| 09/13/2006 | EP1406869B1 Taxol enhancer compounds |
| 09/13/2006 | EP1404685B1 Aryl boronic acids for treating obesity |
| 09/13/2006 | EP1401417A4 Compositions for the treatment of pigmentation disorders and methods for their manufacture |
| 09/13/2006 | EP1395252B1 Medicaments for treating colics |
| 09/13/2006 | EP1392684B1 Thiazole compounds useful as inhibitors of protein kinases |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/13/2006 | EP1345604B1 Use of a alpha-halogen-acryloyl distamycin derivate for the preparation of a medicament for the treatment of cancer |
| 09/13/2006 | EP1343486B1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 09/13/2006 | EP1341813B1 Use of l-carnitine as stabilizing agent of proteins |
| 09/13/2006 | EP1335922B1 Process for preparing 4'-demethyl-4'-O-substituted-1-deoxypodophyllotoxin derivatives and geometric isomers thereof and anti-cancer composition comprising the same |
| 09/13/2006 | EP1335918B1 Novel compounds |
| 09/13/2006 | EP1299400B1 Novel cytotoxic compounds and their use |
| 09/13/2006 | EP1296997B1 Base analogues |
| 09/13/2006 | EP1296645B1 Methods for treating inflammation-mediated conditions of the eye |
| 09/13/2006 | EP1286655B1 Topical composition containing at least one aryl oxime, and method for the preparation thereof |
| 09/13/2006 | EP1284720B1 L-fmau for the treatment of hepatitis delta viral infection |
| 09/13/2006 | EP1274406B1 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 09/13/2006 | EP1267843B1 System for transporting active substances in a biological system |
| 09/13/2006 | EP1246617B1 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of ovarian cancer |
| 09/13/2006 | EP1244621B1 Nitrile derivatives as cathepsin k inhibitors |
| 09/13/2006 | EP1237888B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/13/2006 | EP1230215B1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 09/13/2006 | EP1229938B1 Potentiation of the activity of sn-38 prodrugs |
| 09/13/2006 | EP1224288B1 Processed human chemokine phc-1 |
| 09/13/2006 | EP1221954B1 Methods for identifying inhibitors of methionine aminopeptidases |
| 09/13/2006 | EP1218358B1 Therapeutic quinazoline compounds |
| 09/13/2006 | EP1201236B1 Use of 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol for preventing or treating viral myocarditis |
| 09/13/2006 | EP1200067B1 Method for the preparation of microparticles comprising biological material |
| 09/13/2006 | EP1200040B8 Two-component composition for cosmetic or pharmaceutical use |
| 09/13/2006 | EP1196431B1 A substantially crystalline form of melagatran |
| 09/13/2006 | EP1196154B1 Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
| 09/13/2006 | EP1183050B1 Method for producing an injectable medicament preparation |
| 09/13/2006 | EP1179344B1 Release-regulating preparations |
| 09/13/2006 | EP1088084B1 Erythropoietin analog-human serum albumin fusion protein |
| 09/13/2006 | EP1087951B9 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 09/13/2006 | EP1082319B1 Benzocarbazole and indenoindole derived estrogenic agents |
| 09/13/2006 | EP1082155B1 Dry powder dispersing apparatus and methods for their use |
| 09/13/2006 | EP1079807B1 Use of preparations for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract |
| 09/13/2006 | EP1077986B1 Improvements in macrolide production |
| 09/13/2006 | EP1071402B1 Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants |
| 09/13/2006 | EP1054011B1 Novel antifungal compounds and process for producing the same |
| 09/13/2006 | EP1007656B1 Modified protein kinase a-specific hybrid oligonucleotide in combination with paclitaxol and methods of their use |
| 09/13/2006 | EP0979821B1 Tricyclic compounds |
| 09/13/2006 | EP0965340B1 Dermatologic preparation |
| 09/13/2006 | EP0921774B1 Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | EP0832093B1 Expression of lipoproteins |
| 09/13/2006 | CN1833026A Plant producing hyaluronic acid |
| 09/13/2006 | CN1832966A Polysaccharides derivatives with high antithrombotic activity in plasma |
| 09/13/2006 | CN1832959A Polyethelene glycol link glp-1 compounds |
| 09/13/2006 | CN1832950A Novel phosphonic acid compounds as inhibitors of serine proteases |
| 09/13/2006 | CN1832949A Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 09/13/2006 | CN1832948A 1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 09/13/2006 | CN1832947A Thiazole derivatives as npy antagonists |
| 09/13/2006 | CN1832946A Process for producing imide compound |
| 09/13/2006 | CN1832945A Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 09/13/2006 | CN1832941A Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 09/13/2006 | CN1832940A Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors |
| 09/13/2006 | CN1832939A Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 09/13/2006 | CN1832937A Tacrine derivatives as inhibitors of acetylcholinesterase |
| 09/13/2006 | CN1832935A Therapeutic agents useful for treating pain |
| 09/13/2006 | CN1832934A Benzoxazepine-based compound |
| 09/13/2006 | CN1832932A Biaryl heterocyclic compounds and methods of making and using the same |
| 09/13/2006 | CN1832930A Amide derivative |
| 09/13/2006 | CN1832929A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/13/2006 | CN1832928A 5-membered heterocycle-based p38 kinase inhibitors |
| 09/13/2006 | CN1832927A Novel gamma-secretase inhibitors |
| 09/13/2006 | CN1832926A 6-(2,2,2-trifluoroethylamino)-7-chloro-2,3,4,5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist |
| 09/13/2006 | CN1832925A New p2x7 receptor avtagonists and their use |
| 09/13/2006 | CN1832922A Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides |
| 09/13/2006 | CN1832921A Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 09/13/2006 | CN1832890A Stabilized pharmaceutical product |
| 09/13/2006 | CN1832763A Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects |